All Pharma News
Aerami to Present Data Supporting AER-901 Dosing Regimen at CHEST 2023

Aerami to Present Data Supporting AER-901 Dosing Regimen at CHEST 2023
GLOBENEWSWIRE
05 Oct 2023
Share Share
Aerami Announces Presentation of Phase 1 Trial Data for Lead Program AER-901

Aerami Announces Presentation of Phase 1 Trial Data for Lead Program AER-901
GLOBENEWSWIRE
12 Sep 2023
Share Share
Aerami Therapeutics Expands Management Team

Aerami Therapeutics Expands Management Team
CONTRACT PHARMA
02 Jun 2023
Share Share
Aerami Therapeutics Appoints Joshua Ziel as COO and Interim CEO

Aerami Therapeutics Appoints Joshua Ziel as COO and Interim CEO
GLOBENEWSWIRE
01 Jun 2023
Share Share
Aerami Announces Pharmacokinetic Data Demonstrating the Potential of AER-901

Aerami Announces Pharmacokinetic Data Demonstrating the Potential of AER-901
GLOBENEWSWIRE
24 May 2023
Share Share
Aerami Therapeutics to Present Pharmacokinetic Data Supporting AER-901

Aerami Therapeutics to Present Pharmacokinetic Data Supporting AER-901
GLOBENEWSWIRE
11 May 2023
Share Share
Aerami Therapeutics Mourns the Sudden Loss of Chief Executive Officer Lisa

Aerami Therapeutics Mourns the Sudden Loss of Chief Executive Officer Lisa
GLOBENEWSWIRE
05 May 2023
Share Share
Aerami Therapeutics CEO Lisa Yañez passes away, lead heart disease biotech

Aerami Therapeutics CEO Lisa Yañez passes away, lead heart disease biotech
Kyle LaHucik ENDPTS
05 May 2023
Share Share
Aerami to Investor Day with Leading Experts in Pulmonary Hypertension

Aerami to Investor Day with Leading Experts in Pulmonary Hypertension
GLOBENEWSWIRE
03 Apr 2023
Share Share
Aerami Therapeutics Announces Expansion of the AER-901 Development Program

Aerami Therapeutics Announces Expansion of the AER-901 Development Program
GLOBENEWSWIRE
23 Feb 2023
Share Share